These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 12973656)

  • 1. Angelman syndrome reviewed from a neurophysiological perspective. The UBE3A-GABRB3 hypothesis.
    Dan B; Boyd SG
    Neuropediatrics; 2003 Aug; 34(4):169-76. PubMed ID: 12973656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered ultrasonic vocalization and impaired learning and memory in Angelman syndrome mouse model with a large maternal deletion from Ube3a to Gabrb3.
    Jiang YH; Pan Y; Zhu L; Landa L; Yoo J; Spencer C; Lorenzo I; Brilliant M; Noebels J; Beaudet AL
    PLoS One; 2010 Aug; 5(8):e12278. PubMed ID: 20808828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GABA and epileptogenesis: comparing gabrb3 gene-deficient mice with Angelman syndrome in man.
    DeLorey TM; Olsen RW
    Epilepsy Res; 1999 Sep; 36(2-3):123-32. PubMed ID: 10515160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sleep disturbances in Ube3a maternal-deficient mice modeling Angelman syndrome.
    Colas D; Wagstaff J; Fort P; Salvert D; Sarda N
    Neurobiol Dis; 2005 Nov; 20(2):471-8. PubMed ID: 15921919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mouse models of Angelman syndrome, a neurodevelopmental disorder, display different brain regional GABA(A) receptor alterations.
    Sinkkonen ST; Homanics GE; Korpi ER
    Neurosci Lett; 2003 Apr; 340(3):205-8. PubMed ID: 12672542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From electrophysiology to chromatin: a bottom-up approach to Angelman syndrome.
    Dan B; Servais L; Boyd SG; Wagstaff J; Cheron G
    Ann N Y Acad Sci; 2004 Dec; 1030():599-611. PubMed ID: 15659843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mice lacking the beta3 subunit of the GABAA receptor have the epilepsy phenotype and many of the behavioral characteristics of Angelman syndrome.
    DeLorey TM; Handforth A; Anagnostaras SG; Homanics GE; Minassian BA; Asatourian A; Fanselow MS; Delgado-Escueta A; Ellison GD; Olsen RW
    J Neurosci; 1998 Oct; 18(20):8505-14. PubMed ID: 9763493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parental imprinting and Angelman syndrome.
    Lalande M; Minassian BA; DeLorey TM; Olsen RW
    Adv Neurol; 1999; 79():421-9. PubMed ID: 10514831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal electrophysiological phenotypes and sleep deficits in a mouse model of Angelman Syndrome.
    Copping NA; Silverman JL
    Mol Autism; 2021 Feb; 12(1):9. PubMed ID: 33549123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implications of slow waves and shifting epileptiform discharges in Angelman syndrome.
    Yum MS; Lee EH; Kim JH; Ko TS; Yoo HW
    Brain Dev; 2013 Mar; 35(3):245-51. PubMed ID: 22704603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lovastatin suppresses hyperexcitability and seizure in Angelman syndrome model.
    Chung L; Bey AL; Towers AJ; Cao X; Kim IH; Jiang YH
    Neurobiol Dis; 2018 Feb; 110():12-19. PubMed ID: 29097328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angelman syndrome: correlations between epilepsy phenotypes and genotypes.
    Minassian BA; DeLorey TM; Olsen RW; Philippart M; Bronstein Y; Zhang Q; Guerrini R; Van Ness P; Livet MO; Delgado-Escueta AV
    Ann Neurol; 1998 Apr; 43(4):485-93. PubMed ID: 9546330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linkage disequilibrium at the Angelman syndrome gene UBE3A in autism families.
    Nurmi EL; Bradford Y; Chen Y; Hall J; Arnone B; Gardiner MB; Hutcheson HB; Gilbert JR; Pericak-Vance MA; Copeland-Yates SA; Michaelis RC; Wassink TH; Santangelo SL; Sheffield VC; Piven J; Folstein SE; Haines JL; Sutcliffe JS
    Genomics; 2001 Sep; 77(1-2):105-13. PubMed ID: 11543639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electroclinical characteristics of seizures-comparing Prader--Willi syndrome with Angelman syndrome.
    Wang PJ; Hou JW; Sue WC; Lee WT
    Brain Dev; 2005 Mar; 27(2):101-7. PubMed ID: 15668048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurological aspects of the Angelman syndrome.
    Williams CA
    Brain Dev; 2005 Mar; 27(2):88-94. PubMed ID: 15668046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Episodic tremors representing cortical myoclonus are characteristic in Angelman syndrome due to UBE3A mutations.
    Goto M; Saito Y; Honda R; Saito T; Sugai K; Matsuda Y; Miyatake C; Takeshita E; Ishiyama A; Komaki H; Nakagawa E; Sasaki M; Uto C; Kikuchi K; Motoki T; Saitoh S
    Brain Dev; 2015 Feb; 37(2):216-22. PubMed ID: 24796722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ube3a reinstatement identifies distinct developmental windows in a murine Angelman syndrome model.
    Silva-Santos S; van Woerden GM; Bruinsma CF; Mientjes E; Jolfaei MA; Distel B; Kushner SA; Elgersma Y
    J Clin Invest; 2015 May; 125(5):2069-76. PubMed ID: 25866966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GABAergic Neuron-Specific Loss of Ube3a Causes Angelman Syndrome-Like EEG Abnormalities and Enhances Seizure Susceptibility.
    Judson MC; Wallace ML; Sidorov MS; Burette AC; Gu B; van Woerden GM; King IF; Han JE; Zylka MJ; Elgersma Y; Weinberg RJ; Philpot BD
    Neuron; 2016 Apr; 90(1):56-69. PubMed ID: 27021170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strain-dependence of the Angelman Syndrome phenotypes in Ube3a maternal deficiency mice.
    Born HA; Dao AT; Levine AT; Lee WL; Mehta NM; Mehra S; Weeber EJ; Anderson AE
    Sci Rep; 2017 Aug; 7(1):8451. PubMed ID: 28814801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of dopaminergic neurons and resulting behavioural deficits in mouse model of Angelman syndrome.
    Mulherkar SA; Jana NR
    Neurobiol Dis; 2010 Dec; 40(3):586-92. PubMed ID: 20696245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.